The Promises and Realities of Cellular Therapy: Are We Ready for the Revolution?

Virtual event attendees will gain a holistic view of cell therapy from beginning to end, including perspectives from industry leaders as well a patient who has benefitted from the therapy. 

The format will consist of panel discussions delving into several areas including: 

Where the field of cell therapy is headed, including new modalities, common challenges to avoid, and cutting edge technologies 

Manufacturability including supply chain challenges, time-to-market, value for money, need for collaboration and lessons learned from the scale-up of antibody products 

A leukaemia patient and his drug developer share their unique perspective and how their journeys converged.


Matthew Durdy - Chief Executive Officer, Cell & Gene Therapy Catapult

See full agenda, including the full list of speakers and register here


Discover who we are